Clinical trial
Evaluation of Chemotherapy Prior to Surgery With or Without Zometa for Women…
NCT00242203 · Washington University School of Medicine, Other · Completed
Key facts
| NCT number | NCT00242203 |
|---|---|
| Title | Evaluation of Chemotherapy Prior to Surgery With or Without Zometa for Women With Locally Advanced Breast Cancer |
| Official title | Impact of Neoadjuvant Chemotherapy With or Without Zometa on Occult Micrometastases and Bone Density in Women With Locally Advanced Breast Cancer |
| Lead sponsor | Washington University School of Medicine, Other |
| Collaborators | Novartis Industry Pfizer |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Neoplasms |
| Intervention type | Drug, Procedure, Radiation |
| Interventions | Zometa, Epirubicin, Docetaxel, Trastuzumab, External beam radiation, Modified radical mastectomy or breast conserving surgery with axillary lymph node dissection |
| Enrollment | 120 |
| Start date | Oct 1, 2002 |
| Primary completion | Aug 1, 2007 |
| Completion | May 1, 2011 |
| First posted | Oct 19, 2005 |
| Last update posted | Aug 13, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: